Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 11 '26)

Image
By G.M.

 


    Ann Intern Med

  1. TERAN-PLASENCIA JM, Kalil AC
    In adults hospitalized with acute HF, predischarge influenza vaccination reduced a composite of mortality or readmission at 1 y.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04799.
    PubMed         Abstract available

  2. TONG SYC, Gibney KB
    In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05209.
    PubMed         Abstract available


    Arch Virol

  3. YAN Y, Pan Z, Mao L, Niu P, et al
    Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023.
    Arch Virol. 2026;171:38.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  4. HUANG A, Li C, Wu H, Sun W, et al
    Development of human single-domain antibodies against influenza based on NA-targeting IgG.
    Biochem Biophys Res Commun. 2026;798:153238.
    PubMed         Abstract available

  5. PARLAYAN C, Saadat KASM, Tekayev M, Barez SR, et al
    Leveraging genomic conservation in emerging SARS-CoV-2 variants for precision diagnostics, vaccines, and RNAi therapeutics.
    Biochem Biophys Res Commun. 2026;797:153176.
    PubMed         Abstract available


    BMC Pediatr

  6. MOREIRA RRB, Pereira HMD, Bernardes ALF, Altafini DD, et al
    Surveillance of bloodstream infections in pediatric patients for 11 years: what was the COVID-19 impact?
    BMC Pediatr. 2025;26:11.
    PubMed         Abstract available


    Cell

  7. REFFSIN S, Miller J, Ayyanathan K, Dunagin MC, et al
    Single-cell susceptibility to viral infection is driven by variable cell states.
    Cell. 2026;189:179-195.
    PubMed         Abstract available


    Epidemiol Infect

  8. CAMPOS MENA S, Perez-Gimeno G, Lorusso N, Alvarez Rio V, et al
    Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.
    Epidemiol Infect. 2025;154:e5.
    PubMed         Abstract available

  9. JARRATT R, Clough H, Wilkinson E, Vivancos R, et al
    The Eat-Out-to-Help-Out incentive: A trigger for gastrointestinal infections in England, 2020?
    Epidemiol Infect. 2025;154:e3.
    PubMed         Abstract available

  10. JIMENEZ-RICO MA, Novelo-Perez DF, Puch-Magana CI, Manrique-Puch RA, et al
    Respiratory virus dynamics in a tropical region: Insights from Yucatan, Mexico (2018-2024).
    Epidemiol Infect. 2026;154:e7.
    PubMed         Abstract available

  11. MURAKAMI M, Yamagata M, Miura A
    The impact of COVID-19 infection experience on risk perception and preventive behaviour: a cohort study.
    Epidemiol Infect. 2026;154:e4.
    PubMed         Abstract available


    J Epidemiol Community Health

  12. CAMACHO C, Bower P, Webb RT, Munford L, et al
    Assessing the relationship between community resilience and health outcomes: an observational local-authority level study in England.
    J Epidemiol Community Health. 2026;80:73-79.
    PubMed         Abstract available

  13. FONG WLE, Beale S, Nguyen V, Kovar J, et al
    Estimating the risk of post-COVID condition in deprived communities, migrants and ethnic minorities in England: findings from Virus Watch-a prospective community cohort study.
    J Epidemiol Community Health. 2026;80:114-121.
    PubMed         Abstract available


    J Infect

  14. YUE M, Lee S, Tao S, Tomazetto G, et al
    Upper airway transcriptomics early after SARS-CoV-2 infection to identify individuals likely to develop symptomatic infection.
    J Infect. 2025;92:106664.
    PubMed         Abstract available

  15. KELLY E, Greenland M, de Whalley P, Macaulay GC, et al
    Reactogenicity and Immunogenicity following Heterologous and Homologous Third Dose COVID-19 vaccination in UK Adolescents (Com-COV3): A Randomised Controlled Non-Inferiority Trial.
    J Infect. 2025 Dec 1:106663. doi: 10.1016/j.jinf.2025.106663.
    PubMed         Abstract available


    J Virol

  16. DALY RE, Feng CY, Hesser CR, Myasnikov I, et al
    N-terminal acetylation controls multiple functional aspects of the influenza A virus ribonuclease PA-X.
    J Virol. 2026 Jan 9:e0199925. doi: 10.1128/jvi.01999.
    PubMed         Abstract available

  17. PRASAI K, Yang Z, Guan M, Li T, et al
    Intrahost HA polymorphisms and culture adaptation shape antigenic profiles of H3N2 influenza viruses.
    J Virol. 2026 Jan 7:e0177525. doi: 10.1128/jvi.01775.
    PubMed         Abstract available

  18. BI Z
    Adaptation differences and mechanisms of influenza viruses to ANP32 proteins across species.
    J Virol. 2026 Jan 5:e0190025. doi: 10.1128/jvi.01900.
    PubMed         Abstract available


    J Virol Methods

  19. WANG J, Li R, Liu L, Yu J, et al
    Development and application of a real-time RT-PCR assay for the specific detection of influenza D virus.
    J Virol Methods. 2026;342:115338.
    PubMed         Abstract available


    N Engl J Med

  20. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509810.
    PubMed         Abstract available


    Pediatrics

  21. HAYEK H, Noble EK, Stewart LS, Sahni LC, et al
    Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions.
    Pediatrics. 2026 Jan 9:e2025072184. doi: 10.1542/peds.2025-072184.
    PubMed         Abstract available


    PLoS Biol

  22. EALES O, McCaw JM, Shearer FM
    Modeling of H5N1 influenza virus kinetics during dairy cattle infection suggests the timing of infectiousness.
    PLoS Biol. 2026;24:e3003586.
    PubMed         Abstract available


    PLoS Comput Biol

  23. DAVIS CN, Hill EM, Jewell CP, Rysava K, et al
    A modelling assessment of the impact of control measures on highly pathogenic avian influenza transmission in poultry in Great Britain.
    PLoS Comput Biol. 2026;22:e1013874.
    PubMed         Abstract available

  24. WU SX, Davis CN, Arnold M, Tildesley MJ, et al
    The role of ducks in detecting Highly Pathogenic Avian Influenza in small-scale backyard poultry farms.
    PLoS Comput Biol. 2026;22:e1013357.
    PubMed         Abstract available


    PLoS One

  25. VALDIVIA-GAGO A, Garcia PJ, Harper SL, Soria A, et al
    "What's the point, when we're already dead?" Implementation challenges of COVID-19 public policies for indigenous peoples in the Peruvian Amazon: A sequential multi-method qualitative study.
    PLoS One. 2026;21:e0340774.
    PubMed         Abstract available

  26. WAGNER F, Kolanisi U, Wagner RG, Makuapane LP, et al
    Effect of returning home on university student hunger during South African COVID-19 lockdown.
    PLoS One. 2026;21:e0340350.
    PubMed         Abstract available

  27. BAGULEY E, Knaub M, VanDyke J, Hirschfield G, et al
    Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study.
    PLoS One. 2026;21:e0340475.
    PubMed         Abstract available

  28. TALBOT Q, Batung E, Yusuf I, Omorodion F, et al
    Stigma and labelling of immigrant personal support workers during COVID-19 pandemic in Ontario: Implications for policy.
    PLoS One. 2026;21:e0340589.
    PubMed         Abstract available

  29. OLSSON I, Nilsson AC, Didriksson I, Frigyesi A, et al
    Aetiology and impact of bacterial bloodstream infections in mechanically ventilated COVID-19 patients: A prospective Swedish multicenter cohort study.
    PLoS One. 2026;21:e0340476.
    PubMed         Abstract available

  30. ABBAS S, Nasir JA, Sherwani RAK
    Estimating the economic burden of COVID-19 survivors in Punjab, Pakistan.
    PLoS One. 2026;21:e0337995.
    PubMed         Abstract available

  31. VICTORINO DB, Malheiros JM, Ten-Caten F, Cardoso Betta VH, et al
    Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome.
    PLoS One. 2026;21:e0338519.
    PubMed         Abstract available

  32. XUE Z, Pi P, Liu Z, Zeng Z, et al
    MedNeXt for accurate medical image classification and segmentation: A lightweight transformer-style convolutional neural network.
    PLoS One. 2026;21:e0340108.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  33. ZHANG R, Deng R, Liu S, Yao Q, et al
    Reconstructing the early spatial spread of pandemic respiratory viruses in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2518051123.
    PubMed         Abstract available

  34. VERMA AK, Tan L, Schuster N, Moye SL, et al
    Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2026;123:e2530209123.
    PubMed         Abstract available

  35. ZHANG Y, Silvestre-Roig C, Fu H, Alimohamadi H, et al
    SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting.
    Proc Natl Acad Sci U S A. 2026;123:e2521841122.
    PubMed         Abstract available


    Vaccine

  36. LISTER H, Farquharson K, Seale H, Smith LE, et al
    A systematic review of the impact of vaccine reactogenicity on willingness to accept influenza vaccination in adults.
    Vaccine. 2026;74:128195.
    PubMed         Abstract available

  37. YOKOYAMA Y, Yao S, Cozza R, Gil F, et al
    A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged mice.
    Vaccine. 2026;74:128189.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »